Approval · Notice of Compliance 21742 · 2019
PATADAY: Notice of Compliance 21742
Issued January 14, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21742
- Date
- January 14, 2019
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- The submission was filed in order for the package insert to be reviewed
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PATADAY | Not yet assigned | — |
Medicinal ingredients
- OLOPATADINE HCL 2.22 MG per ML